Contraceptive Technology Update – October 1, 2013
October 1, 2013
View Issues
-
Boost HPV vaccination numbers — next generation is at risk
Vaccination for human papillomavirus (HPV) rates in US girls ages 13-17 failed to increase between 2011 and 2012. -
High demand, production delay limit Skyla IUD
Providers might need to seek other long-acting reversible contraceptive methods other than the new smaller levonorgestrel intrauterine device, Skyla. -
Help college-age women plan forward with LARCs
Long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and the contraceptive implant, can help young women achieve their goals. -
For gestational diabetes, check prior status
It is critical to address contraception at each interconception visit with women with prior gestational diabetes mellitus (GDM). -
Gonorrhea treatments offer 2 new options
Results of a trial conducted by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health indicate two new antibiotic regimens. -
Nonhormonal options eyed for contraception
Enrollment for a 3,200-subject Phase III registration study has been completed for Amphora, a non-hormonal contraceptive gel.